Explore how rapid next-generation sequencing (NGS) is transforming precision oncology by providing timely molecular profiling ...
Four recent breakthroughs in proteomics that are changing the way we sequence, synthesize and discover proteins.
The global clinical laboratory services market was valued at USD 274.6 billion in 2025 and is forecast to reach USD 468.2 billion by 2036, rising from USD 298.4 billion in 2026 at a 4.6% CAGR. Growth ...
Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced that commercial shipments of the PrepQuant™ System have begun in North America.
On July 16, 2026, the Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC) ...
The global market is projected to reach $307.9 billion by 2030 at a 6.5% CAGR, as rising cancer incidence, digital pathology, ...
In July 2026, Median obtained CE Mark for eyonis® LCS under Regulation (EU) 2017/745 (MDR), extending its regulatory footprint across the European Economic Area. The Company's iCRO business continues ...
As sequencing continues to grow in importance across biotherapeutic discovery and development, where can it make the biggest ...
Pillar Biosciences, a global manufacturer and provider of next-generation sequencing (NGS) kitted solutions, today announced the appointments of Todd Christian and Yann Echelard, Ph.D., to its Board ...
Cell and gene therapies have entered a new phase of maturity. Scientific innovation continues at an unprecedented pace, but ...
Electronic health record training now encompasses clinical reasoning, patient safety, workflow management and oversight of AI ...
Highlights From Community Oncology Global Congress 2026, Day 2 / Abena Yeboah Aduse-Poku, Adedayo Joseph, Arturo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results